Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-12

Clinical Trial Update: Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria

View source ↗

Summary

Clinical trial update on artesunate plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: University of Oxford | Conditions: Falciparum Malaria | Status: COMPLETED